Cherry Hill, NJ, United States of America

David Nugiel

USPTO Granted Patents = 7 

Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 32(Granted Patents)


Location History:

  • Wilmington, DE (US) (2011)
  • Cherry Hill, NJ (US) (2002 - 2015)

Company Filing History:


Years Active: 2002-2015

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of David Nugiel

Introduction

David Nugiel is a prominent inventor based in Cherry Hill, NJ (US), known for his significant contributions to the field of pharmaceuticals. With a total of seven patents to his name, Nugiel has made remarkable strides in developing compounds that address critical health issues.

Latest Patents

Among his latest patents, Nugiel has developed ethanamine compounds and methods of using the same. This invention focuses on pharmaceutical compositions that can be used to treat depression by administering the ethanamine compound. Another notable patent involves 4-quinolinemethanols as anti-malarial agents. This invention relates to substituted 4-quinolinemethanols and pharmaceutical compositions that can be utilized for treating malaria, tuberculosis, and other infectious diseases.

Career Highlights

Throughout his career, Nugiel has worked with leading pharmaceutical companies, including Bristol-Myers Squibb and AstraZeneca. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Nugiel has collaborated with several notable professionals in his field, including David J. Carini and Eddy W. Yue. These collaborations have further enhanced his innovative capabilities and expanded the impact of his work.

Conclusion

David Nugiel's contributions to pharmaceutical innovations demonstrate his commitment to improving health outcomes through his inventions. His work continues to influence the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…